Show simple item record

dc.rights.licenseopenen_US
dc.contributor.authorHILLIQUIN, D.
dc.contributor.authorLE GUERN, R.
dc.contributor.authorTHEPOT SEEGERS, V.
dc.contributor.authorNEULIER, C.
dc.contributor.authorLOMONT, A.
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorMARIE, Véronique
dc.contributor.authorLEGEAY, C.
dc.contributor.authorMERRER, J.
dc.contributor.authorLEPELLETIER, D.
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorROGUES, Anne-Marie
dc.contributor.authorGRANDBASTIEN, B.
dc.contributor.authorLUCET, J. C.
dc.contributor.authorZAHAR, J. R.
dc.date.accessioned2020-11-16T14:41:50Z
dc.date.available2020-11-16T14:41:50Z
dc.date.issued2018-03
dc.identifier.issn1532-2939 (Electronic) 0195-6701 (Linking)en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/14035
dc.description.abstractEnCohorting carbapenemase-producing Enterobacteriaceae (CPE) carriers during hospitalisation limits the in hospital spreading. Our objective was to identify risk factors for CPE acquisition among contacts of an index patient in non-cohorted populations. A multicentre retrospective matched case-control study was conducted in five hospitals. Each contact patient (case) who acquired Klebsiella pneumoniae OXA-48 from an index patient was compared to three contact (controls) with the same index patients matched with hospitalization in the same unit and similar exposure-times. Fifty-one secondary cases and 131 controls were included. By univariate analysis exposure time (OR=1.06; 95% CI = 1.02 - 1.1; p = 0.006), concomitant infection at admission (OR=3.23; 95% CI = 1.42 - 7.35; p = 0.005), antimicrobial therapy within the last month before hospitalization (OR=2.88; 95% CI = 1.34- 6.2; p = 0.007), antimicrobial therapy during the exposure-time (OR=5.36; 95% CI = 2.28 - 12.6; p < 0.001), use of at least one invasive procedure (OR=2.99; 95% CI = 1.25 - 7.15; p = 0.014), number of invasive procedure (OR=1.52; 95%CI = 1.05 - 2.19; p=0.025), and the geographical proximity (OR=2.84; 95% CI = 1.15 - 7.00; p = 0.023) were associated with CPE acquisition. By multivariate analysis, antimicrobial therapy during the exposure-time (OR=6.36; 95% CI = 2.46 - 16.44; p < 0.001), at least one invasive procedure (OR=2.92; 95%CI=1.04-8.17; p=0.041), and geographical proximity (OR=3.69; 95% CI = 1.15 - 11.86; p = 0.028) were associated with acquisition. In this study, geographical proximity, invasive procedure and antimicrobial therapy during exposure-time were significantly associated with KP-OXA-48 acquisition.
dc.language.isoENen_US
dc.subject.enPharmacoEpi-Drugs
dc.title.enRisk factors for acquisition of OXA-48-producing Klebsiella pneumonia among contact patients: a multicentre study
dc.title.alternativeJ Hosp Infecten_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1016/j.jhin.2017.08.024en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed28882642en_US
bordeaux.journalThe Journal of hospital infectionen_US
bordeaux.page253-259en_US
bordeaux.volume98en_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - U1219en_US
bordeaux.issue3en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.teamPharmacoEpi-Drugsen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.exportfalse
bordeaux.COinSctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft.jtitle=The%20Journal%20of%20hospital%20infection&amp;rft.date=2018-03&amp;rft.volume=98&amp;rft.issue=3&amp;rft.spage=253-259&amp;rft.epage=253-259&amp;rft.eissn=1532-2939%20(Electronic)%200195-6701%20(Linking)&amp;rft.issn=1532-2939%20(Electronic)%200195-6701%20(Linking)&amp;rft.au=HILLIQUIN,%20D.&amp;LE%20GUERN,%20R.&amp;THEPOT%20SEEGERS,%20V.&amp;NEULIER,%20C.&amp;LOMONT,%20A.&amp;rft.genre=article


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record